-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Design Therapeutics, Inc. quarterly/annual Revenues history and growth rate from 2024 to Q1 2025.
- Design Therapeutics, Inc. Revenues for the quarter ending March 31, 2025 was $0.000.